Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial. [electronic resource]
Producer: 20140220Description: 2453-61 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Aged, 80 and over
- Androstadienes -- therapeutic use
- Aromatase Inhibitors -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- ErbB Receptors -- metabolism
- Female
- Humans
- Middle Aged
- Molecular Sequence Data
- Prognosis
- Prospective Studies
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Selective Estrogen Receptor Modulators -- therapeutic use
- Tamoxifen -- therapeutic use
- Tissue Array Analysis
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.